Investor Type | Firm |
Industries | BioTech • AgroTech • CleanTech • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Healthcare (& Wellness) |
Stages | Seed, Series A, Series B, Pre-seed |
Investing | United States • United Kingdom |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
MBX Capital is a venture capital firm focused on fostering good health for everyone by investing in environmental health and healthcare infrastructure startups. They channel their investments toward companies that address the root causes of illnesses and strive to revolutionize healthcare services, material science, and clean technology. With a keen eye on innovative startups in BioTech, AgroTech, CleanTech, HealthTech & Fitness, Material Science, Medical Devices & Hospital Services, Real Estate & Construction, and Healthcare & Wellness, they provide crucial funding and support across various growth stages. MBX Capital's funding strategy includes participating in Seed, Series A, Series B, and Pre-seed funding rounds. They are open to investing amounts ranging from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot of $1,500,000 for their investments, catering to the unique needs of emerging startups with transformative potential. Among the companies MBX Capital has partnered with are Tidal Vision for green chemistry solutions, Junction Health for community health infrastructure, Examol for computational chemistry cloud infrastructure, and numerous others focusing on indoor air pollution, precision health testing, medical financial aid, medication management, and various health technologies. The firm proudly showcases a roster of partnered companies and co-investors, indicating a collaborative approach to venture capital. They have also celebrated successful exits, such as SecureAire's acquisition and Vaxxinity's IPO, demonstrating a track record of identifying and supporting startups with impactful solutions and substantial growth prospects.